SCHEMBL5453397

SCHEMBL5453397

CC(C)NC(=O)Nc1sc2c(c1C(N)=O)CCC(O)C2

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PTPN1 P18031 1/20 0.53
MAPT P10636 4/20 0.53
DUSP3 P51452 1/20 0.53
PTPN5 P54829 1/20 0.53
PTPN11 Q06124 1/20 0.53
ANO1 Q5XXA6 1/20 0.51
TNIK Q9UKE5 1/20 0.50
ALDH1A1 P00352 5/20 0.49
NPC1 O15118 5/20 0.49
RAB9A P51151 5/20 0.49
POLB P06746 1/20 0.49
AIP O00170 1/20 0.49
SGTA O43765 1/20 0.49
TOMM70 O94826 1/20 0.49
STIP1 P31948 1/20 0.49
PPP5C P53041 1/20 0.49
DNAJC7 Q99615 1/20 0.49
STUB1 Q9UNE7 1/20 0.49
FLT3 P36888 2/20 0.48
KMT2A Q03164 4/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5462746 0.88 MAPT (0.69) MAPTDUSP3PTPN5PTPN11ANO1
SCHEMBL8290431 0.85 ANO1 (0.72) MAPTDUSP3PTPN5PTPN11ANO1
SCHEMBL5449286 0.83 PTPN1 (0.55) PTPN1MAPTDUSP3PTPN5PTPN11
SCHEMBL5454129 0.82 PTPN1 (0.52) PTPN1MAPTDUSP3PTPN5PTPN11
SCHEMBL8289710 0.82 KDM4E (0.70) MAPTANO1ALDH1A1NPC1RAB9A
SCHEMBL5459748 0.82 FLT3 (0.70) MAPTANO1ALDH1A1NPC1RAB9A
SCHEMBL5446191 0.82 TNIK (0.59) PTPN1MAPTDUSP3PTPN5PTPN11
SCHEMBL8290436 0.81 FLT3 (0.68) MAPTANO1ALDH1A1NPC1RAB9A
SCHEMBL5455042 0.80 FLT3 (0.70) PTPN1MAPTDUSP3PTPN5PTPN11
SCHEMBL5451302 0.80 FLT3 (0.70) PTPN1MAPTDUSP3PTPN5PTPN11

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20070275962-A1 Heterobicyclic Compounds as Pharmaceutically Active Agents GPC BIOTECH AG (DE) 2007-11-29 US claimed
US-20070275962-A1 Heterobicyclic Compounds as Pharmaceutically Active Agents GPC BIOTECH AG (DE) 2007-11-29 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070275962-A1 Heterobicyclic Compounds as Pharmaceutically Active Agents TBCA, PARK7, NFATC1 PTPN1 2192/4885MAPT 21/4885DUSP3 110/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.